GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Boston Scientific Corporation (BSX) [hlAlert]

Rating:
Mkt Outperform
BSX
up 200.88 %

Boston Scientific Corporation (BSX) upgraded to Mkt Outperform by JMP Securities

Posted on: Monday,  Dec 3, 2012  8:25 AM ET by JMP Securities

JMP Securities rated Mkt Outperform Boston Scientific Corporation (NYSE: BSX) on 12/03/2012, when the stock price was $5.63.
Since then, Boston Scientific Corporation has gained 200.89% as of 10/28/2015's recent price of $16.94.
If you would have followed this JMP Securities's recommendation on BSX, you would have gained 200.88% of your investment in 1059 days.

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.

MP Securities' equity research department provides institutional clients with comprehensive industry knowledge, unique insight and actionable information. JMP's senior research analysts are charged with developing proprietary investment themes, anticipating secular and cyclical changes and producing action-oriented reports. JMP follows companies in six industries that exhibit above-average long-term growth characteristics — Technology, Healthcare, Consumer, Real Estate, Financial Services and Business Services — and produces specialized equity research that enables investors to understand and invest in complicated growth stocks profitably.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/3/2012 8:25 AM Buy
None
5.63
as of 12/31/2012
1 Week down  -0.86 %
1 Month up  1.77 %
3 Months up  1.77 %
1 YTD up  1.77 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/1/2009 8:25 AM Hold
None
10.45

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy